ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC82.69

C82.69

Billable

Cutaneous follicle center lymphoma, extranodal and solid organ sites

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C82.69 is a billable code used to indicate a diagnosis of cutaneous follicle center lymphoma, extranodal and solid organ sites.

Key Diagnostic Point:

Cutaneous follicle center lymphoma (CFCL) is a subtype of non-Hodgkin lymphoma that primarily affects the skin and is characterized by the proliferation of follicle center (germinal center) B-cells. When CFCL presents in extranodal and solid organ sites, it indicates a more advanced stage of the disease, where the lymphoma has spread beyond the skin to other organs such as the liver, spleen, or lymph nodes. Patients may present with localized skin lesions, which can be nodular or plaque-like, and may experience systemic symptoms. The disease can be indolent or aggressive, and its clinical behavior can vary significantly. Staging is crucial for determining the extent of the disease and guiding treatment, which may include chemotherapy, radiation therapy, or targeted therapies. B-symptoms, such as fever, night sweats, and weight loss, may also be present and are indicative of a more systemic involvement of the lymphoma. Accurate diagnosis often requires a biopsy and histological examination to confirm the presence of follicle center cells.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiation from other types of lymphomas
  • Need for precise staging information
  • Variability in clinical presentation
  • Documentation of B-symptoms

Audit Risk Factors

  • Inadequate documentation of staging
  • Failure to document B-symptoms
  • Misclassification of lymphoma subtype
  • Lack of supporting pathology reports

Specialty Focus

Medical Specialties

Hematology/Oncology

Documentation Requirements

Comprehensive documentation of diagnosis, staging, treatment plan, and follow-up.

Common Clinical Scenarios

Diagnosis of CFCL, treatment planning, and management of complications.

Billing Considerations

Ensure accurate staging and documentation of any systemic symptoms.

Dermatology

Documentation Requirements

Detailed descriptions of skin lesions, biopsy results, and treatment responses.

Common Clinical Scenarios

Initial presentation of skin lesions, management of localized disease.

Billing Considerations

Document any changes in skin lesions and systemic symptoms.

Coding Guidelines

Inclusion Criteria

Use C82.69 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the diagnosis, staging, and any associated symptoms
  • Include details on the site of involvement and any relevant laboratory or imaging findings

Exclusion Criteria

Do NOT use C82.69 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

85041CPT Code

Complete blood count (CBC) with differential

Clinical Scenario

Used to assess overall health and detect blood disorders in patients with CFCL.

Documentation Requirements

Document the reason for the CBC and any relevant findings.

Specialty Considerations

Hematology specialists should ensure that all relevant lab results are included in the patient's record.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of lymphomas, including CFCL, which aids in better tracking of disease prevalence and treatment outcomes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of lymphomas, including CFCL, which aids in better tracking of disease prevalence and treatment outcomes.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of lymphomas, including CFCL, which aids in better tracking of disease prevalence and treatment outcomes.

Resources

Clinical References

  • •
    American Cancer Society - Lymphoma

Coding & Billing References

  • •
    American Cancer Society - Lymphoma

Frequently Asked Questions

What are the common symptoms of cutaneous follicle center lymphoma?

Common symptoms include skin lesions, which may be nodular or plaque-like, and systemic B-symptoms such as fever, night sweats, and weight loss.